Fresenius Medical Care AG (FMS) Net Income towards Common Stockholders (2009 - 2026)

Fresenius Medical Care AG's Net Income towards Common Stockholders history runs 18 years deep, the most recent figure standing at $137.6 million for Q1 2026.

• In Q1 2026, Net Income towards Common Stockholders fell 46.83% year-over-year to $137.6 million; the TTM figure through Mar 2026 stood at $1.2 billion (up 23.53% YoY), while the FY2025 annual figure was $1.5 billion, up 50.55% from the prior year.
• Net Income towards Common Stockholders for Q1 2026 stood at $137.6 million, down from $479.6 million in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was $479.6 million in Q4 2025, with the low at $137.6 million in Q1 2026.
• The 5-year median for Net Income towards Common Stockholders is $228.3 million (2024), against an average of $236.8 million.
• The sharpest annual moves came in 2024 and 2026: Net Income towards Common Stockholders jumped 71.55% in 2024, then plunged 46.83% in 2026.
• Fresenius Medical Care AG's Net Income towards Common Stockholders stood at $258.1 million in 2022, then tumbled by 35.81% to $165.7 million in 2023, then surged by 71.55% to $284.2 million in 2024, then surged by 68.72% to $479.6 million in 2025, then plunged by 71.31% to $137.6 million in 2026.
• Business Quant data shows FMS's Net Income towards Common Stockholders at $137.6 million in Q1 2026, $479.6 million in Q4 2025, and $321.3 million in Q3 2025.